Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Target Family-directed Masterkeys in Chemogenomics

Brand name Ingredient Company Indication Sales (growth) [ billion] [Pg.8]

Celebrex Celecoxib Pharmacia/Pfizer pain, arthritis 3.1 (32%) [Pg.8]

Nexium Esomeprazole AstraZenec ulcers proton pump inhibitor 623 (999%) [Pg.9]

Protonix Pantoprazole Altana/Wyeth ulcers proton pump inhibitor 695 (426%) [Pg.9]

Muller G. (2004) Target family-directed masterkeys in chemogenomics. In H Kubini, G Muller (eds), Chemogenomics in Drug Discovery—A Medicinal Chemistry Perspective, pp. 7-42. Wiley-VCH, Weinheim. [Pg.34]

See other pages where Target Family-directed Masterkeys in Chemogenomics is mentioned: [Pg.7] [Pg.8] [Pg.10] [Pg.12] [Pg.14] [Pg.16] [Pg.18] [Pg.20] [Pg.22] [Pg.24] [Pg.26] [Pg.28] [Pg.30] [Pg.32] [Pg.34] [Pg.36] [Pg.38] [Pg.40] [Pg.7] [Pg.8] [Pg.10] [Pg.12] [Pg.14] [Pg.16] [Pg.18] [Pg.20] [Pg.22] [Pg.24] [Pg.26] [Pg.28] [Pg.30] [Pg.32] [Pg.34] [Pg.36] [Pg.38] [Pg.40] [Pg.7] [Pg.36] [Pg.480] [Pg.482] [Pg.16]

SEARCH

Chemogenomics

Target family

Target family-directed masterkeys

Target-directed